Pharmacoeconomics of opioid therapy for chronic non-malignant pain

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.3, 2002-03, pp. : 229-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Chronic Non-Malignant Pain in the Elderly: Safety Considerations

By > Gibson Stephen J.

Drug Safety, Vol. 32, Iss. 6, 2009-05 ,pp. : 457-474

Adis International

Access to resources Recommend Favorite

Non-Analgesic Effects of Opioids: The Cognitive Effects of Opioids in Chronic Pain of Malignant and Non-Malignant Origin. An Update.

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6116-6122

Bentham Science Publishers

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Guide to Its Use in Chronic Non-Malignant Pain

By Plosker Greg L. Lyseng-Williamson Katherine A.

CNS Drugs, Vol. 26, Iss. 4, 2012-04 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Review of its Use in the Management of Chronic Non-Malignant Pain

By Plosker Greg L.

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2491-2509

Adis International

Access to resources Recommend Favorite

Comparison of Two Oral Morphine Formulations for Chronic Severe Pain of Malignant and Nonmalignant Origin: Kapanol vs MST

By Miller A.J.

Clinical Drug Investigation, Vol. 15, Iss. 1, 1998-01 ,pp. : 69-71

Adis International

Access to resources Recommend Favorite